Jenny Lam1,2, Toshiaki Suzuki3,4, David Bernstein3,4, Beiqun Zhao3,4, Carlos Maeda3,4, Thach Pham3,4, Bryan J Sandler3,4, Garth R Jacobsen3,4, Joslin N Cheverie3,4, Santiago Horgan3,4. 1. Division of Minimally Invasive Surgery, University of San Diego, California, San Diego, CA, USA. jennylam86@gmail.com. 2. Center for the Future of Surgery, University of California at San Diego, MET Building, Lower Level, 9500 Gilman Drive MC 0740, La Jolla, CA, 92093-0740, USA. jennylam86@gmail.com. 3. Division of Minimally Invasive Surgery, University of San Diego, California, San Diego, CA, USA. 4. Center for the Future of Surgery, University of California at San Diego, MET Building, Lower Level, 9500 Gilman Drive MC 0740, La Jolla, CA, 92093-0740, USA.
Abstract
BACKGROUND: Laparoscopic sleeve gastrectomy is the most commonly performed bariatric surgery in the world. Enhanced recovery after surgery (ERAS) protocols have been shown to reduce complications and decrease length of stay for various types of surgeries. In this study, we propose an ERAS protocol for laparoscopic sleeve gastrectomy and compare the clinical outcomes with patients who received standard care. METHODS: We performed a single-institution retrospective analysis in patients who underwent laparoscopic sleeve gastrectomy from February 2015 to December 2017. Patients were stratified into standard care and ERAS protocol groups. The ERAS protocol consisted of goal-directed patient education, specific pre- and post-op multi-modal medication regimen, early ambulation, and early oral intake. Patients were discharged on their first post-operative day if they met appropriate post-surgical milestones. The primary outcomes were length of stay, 7- and 30-day readmission rates, and complication rates. Secondary outcomes included anti-emetic and pain medication utilization, post-operative emesis episodes per day, post-operative pain scores, and mortality. RESULTS: We included 214 consecutive patients who underwent sleeve gastrectomy, 130 were in the ERAS group and 84 were in the standard care group. Median hospital stay was significantly shorter in the ERAS group compared to the standard care group (1 vs. 2 days; p < 0.001). There were no differences in 7- or 30-day readmission rates (1.5 vs. 1.2%; p = 0.838, 2.3 vs. 2.4%; p = 0.966) or post-operative complications (6.2 vs. 3.6%; p = 0.410). The ERAS group also had decreased median intra-operative opioid consumption and self-reported pain scores on post-operative day 1 (27.5 MME vs. 27.4 MME; p = 0.044, 3.3 vs. 3.9; p = 0.046). Mortality rate was 0% overall. CONCLUSION: A cost-effective ERAS protocol for laparoscopic sleeve gastrectomy results in shorter length of stay, without increase in peri-operative morbidity or readmission rates.
BACKGROUND: Laparoscopic sleeve gastrectomy is the most commonly performed bariatric surgery in the world. Enhanced recovery after surgery (ERAS) protocols have been shown to reduce complications and decrease length of stay for various types of surgeries. In this study, we propose an ERAS protocol for laparoscopic sleeve gastrectomy and compare the clinical outcomes with patients who received standard care. METHODS: We performed a single-institution retrospective analysis in patients who underwent laparoscopic sleeve gastrectomy from February 2015 to December 2017. Patients were stratified into standard care and ERAS protocol groups. The ERAS protocol consisted of goal-directed patient education, specific pre- and post-op multi-modal medication regimen, early ambulation, and early oral intake. Patients were discharged on their first post-operative day if they met appropriate post-surgical milestones. The primary outcomes were length of stay, 7- and 30-day readmission rates, and complication rates. Secondary outcomes included anti-emetic and pain medication utilization, post-operative emesis episodes per day, post-operative pain scores, and mortality. RESULTS: We included 214 consecutive patients who underwent sleeve gastrectomy, 130 were in the ERAS group and 84 were in the standard care group. Median hospital stay was significantly shorter in the ERAS group compared to the standard care group (1 vs. 2 days; p < 0.001). There were no differences in 7- or 30-day readmission rates (1.5 vs. 1.2%; p = 0.838, 2.3 vs. 2.4%; p = 0.966) or post-operative complications (6.2 vs. 3.6%; p = 0.410). The ERAS group also had decreased median intra-operative opioid consumption and self-reported pain scores on post-operative day 1 (27.5 MME vs. 27.4 MME; p = 0.044, 3.3 vs. 3.9; p = 0.046). Mortality rate was 0% overall. CONCLUSION: A cost-effective ERAS protocol for laparoscopic sleeve gastrectomy results in shorter length of stay, without increase in peri-operative morbidity or readmission rates.
Authors: Alexander B Stone; Michael C Grant; Claro Pio Roda; Deborah Hobson; Timothy Pawlik; Christopher L Wu; Elizabeth C Wick Journal: J Am Coll Surg Date: 2016-01-07 Impact factor: 6.113
Authors: Wayne J English; Eric J DeMaria; Stacy A Brethauer; Samer G Mattar; Raul J Rosenthal; John M Morton Journal: Surg Obes Relat Dis Date: 2017-12-16 Impact factor: 4.734
Authors: D P Lemanu; P P Singh; K Berridge; M Burr; C Birch; R Babor; A D MacCormick; B Arroll; A G Hill Journal: Br J Surg Date: 2013-01-21 Impact factor: 6.939
Authors: Hugo Meunier; Yannick Le Roux; Anne-Lise Fiant; Yoann Marion; Adrien Lee Bion; Thomas Gautier; Nicolas Contival; Jean Lubrano; Fabienne Fobe; Marion Zamparini; Marie-Astrid Piquet; Véronique Savey; Arnaud Alves; Benjamin Menahem Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: Jaime Ruiz-Tovar; Gilberto Gonzalez; Andrei Sarmiento; Miguel A Carbajo; Javier Ortiz-de-Solorzano; Maria Jose Castro; Jose Maria Jimenez; Lorea Zubiaga Journal: Surg Endosc Date: 2020-01-13 Impact factor: 4.584
Authors: Cory McLaughlin; Anthony I Squillaro; Shadassa Ourshaliman; Ashley Song; Ashwini Lakshmanan; Giovanni Cucchiaro; Matthew Hall; Rita V Burke; Lorraine I Kelley-Quon Journal: Clin Ther Date: 2019-08-10 Impact factor: 3.393
Authors: Jai Scheerhoorn; Lisa van Ede; Misha D P Luyer; Marc P Buise; R Arthur Bouwman; Simon W Nienhuijs Journal: Trials Date: 2022-01-21 Impact factor: 2.279
Authors: Anna S Mierzwa; Valentin Mocanu; Gabriel Marcil; Jerry Dang; Noah J Switzer; Daniel W Birch; Shahzeer Karmali Journal: Obes Surg Date: 2021-08-10 Impact factor: 4.129